Tharimmune Inc

CNTN NASDAQ Santé & Biotech États-Unis
3.21 $
11.95 %

Tharimmune Inc est une société biotechnologique développant des immunothérapies ciblées pour lutter contre les maladies inflammatoires et auto-immunes.

Performance & Momentum

6 Months 21.40 %
1 Year 123.50 %
3 Years 97.75 %
5 Years 99.70 %

Similar stocks to Tharimmune Inc

Anantys Community

Be the first to share your analysis on Tharimmune Inc.

Take control
of your investments

Track your portfolios, analyze your performance and receive personalized insights to invest with strategy.

  • Real-time multi-portfolio tracking
  • AI analysis of your positions
  • Counter your cognitive biases